CN115197236B - Linear type glabra A analogue and preparation and application thereof - Google Patents
Linear type glabra A analogue and preparation and application thereof Download PDFInfo
- Publication number
- CN115197236B CN115197236B CN202210749248.2A CN202210749248A CN115197236B CN 115197236 B CN115197236 B CN 115197236B CN 202210749248 A CN202210749248 A CN 202210749248A CN 115197236 B CN115197236 B CN 115197236B
- Authority
- CN
- China
- Prior art keywords
- linear type
- analogue
- reaction
- pyranocoumarin
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title abstract description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 126
- 238000006243 chemical reaction Methods 0.000 claims abstract description 91
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 81
- 239000002994 raw material Substances 0.000 claims abstract description 42
- 239000002904 solvent Substances 0.000 claims abstract description 40
- 238000010438 heat treatment Methods 0.000 claims abstract description 39
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 32
- 150000001875 compounds Chemical class 0.000 claims abstract description 32
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 27
- 239000012044 organic layer Substances 0.000 claims abstract description 26
- 210000004027 cell Anatomy 0.000 claims abstract description 24
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims abstract description 15
- 240000009022 Smilax rotundifolia Species 0.000 claims abstract description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 14
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 12
- 206010008342 Cervix carcinoma Diseases 0.000 claims abstract description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 7
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims abstract description 7
- 201000010881 cervical cancer Diseases 0.000 claims abstract description 7
- 229940010454 licorice Drugs 0.000 claims abstract description 7
- 206010006187 Breast cancer Diseases 0.000 claims abstract description 6
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 78
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 75
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims description 67
- 229960000956 coumarin Drugs 0.000 claims description 33
- 235000001671 coumarin Nutrition 0.000 claims description 33
- 239000000243 solution Substances 0.000 claims description 31
- YYPNJNDODFVZLE-UHFFFAOYSA-N 3-methylbut-2-enoic acid Chemical compound CC(C)=CC(O)=O YYPNJNDODFVZLE-UHFFFAOYSA-N 0.000 claims description 26
- 238000010992 reflux Methods 0.000 claims description 26
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 25
- 238000001914 filtration Methods 0.000 claims description 23
- 238000001035 drying Methods 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000012043 crude product Substances 0.000 claims description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 13
- 239000003054 catalyst Substances 0.000 claims description 13
- 238000004440 column chromatography Methods 0.000 claims description 13
- 239000005457 ice water Substances 0.000 claims description 13
- 230000007935 neutral effect Effects 0.000 claims description 13
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical class [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 13
- 230000001105 regulatory effect Effects 0.000 claims description 13
- 238000010898 silica gel chromatography Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 11
- 241000245654 Gladiolus Species 0.000 claims description 10
- 210000000081 body of the sternum Anatomy 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 9
- 210000004881 tumor cell Anatomy 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 241000202807 Glycyrrhiza Species 0.000 claims description 6
- 201000007270 liver cancer Diseases 0.000 claims description 6
- 210000005229 liver cell Anatomy 0.000 claims description 6
- 208000014018 liver neoplasm Diseases 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical class [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000000375 suspending agent Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- XLEYFDVVXLMULC-UHFFFAOYSA-N 2',4',6'-trihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=C(O)C=C1O XLEYFDVVXLMULC-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 235000010216 calcium carbonate Nutrition 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical class O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 239000001087 glyceryl triacetate Substances 0.000 claims description 3
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical class OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- 239000011261 inert gas Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- 229940069328 povidone Drugs 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 229960002622 triacetin Drugs 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims 5
- 238000003756 stirring Methods 0.000 abstract description 13
- 238000009987 spinning Methods 0.000 abstract description 10
- 238000002474 experimental method Methods 0.000 abstract description 6
- 230000005918 in vitro anti-tumor Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 20
- 239000007787 solid Substances 0.000 description 16
- 239000013078 crystal Substances 0.000 description 14
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 12
- 239000007789 gas Substances 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 238000004090 dissolution Methods 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 6
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 229940041181 antineoplastic drug Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 4
- RXCVUHMIWHRLDF-HXUWFJFHSA-N 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1-one Chemical compound ClC1=C2CCN(C(C2=C(C(=C1)[C@@H](C1COC1)OC)Cl)=O)CC=1C(NC(=CC=1OC)C)=O RXCVUHMIWHRLDF-HXUWFJFHSA-N 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- ZGFASEKBKWVCGP-UHFFFAOYSA-N cyclocoumarol Chemical compound C12=CC=CC=C2OC(=O)C2=C1OC(OC)(C)CC2C1=CC=CC=C1 ZGFASEKBKWVCGP-UHFFFAOYSA-N 0.000 description 3
- LFUPTQIEOBBAJE-VIFPVBQESA-N gtpl6338 Chemical compound C([C@@H](O1)C)NC(C2=3)=C1C=NC=3SC(C1=O)=C2N=CN1C1=CC=C(Cl)C=C1 LFUPTQIEOBBAJE-VIFPVBQESA-N 0.000 description 3
- KUCDOJMOTMEEOF-UHFFFAOYSA-N gtpl6345 Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(SC=2C3=C4NCCOC4=CN=2)=C3N=C1 KUCDOJMOTMEEOF-UHFFFAOYSA-N 0.000 description 3
- FODONWGPMXPGNC-UHFFFAOYSA-N gtpl6346 Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(SC=2C3=C4NCCOC4=CN=2)=C3N=C1 FODONWGPMXPGNC-UHFFFAOYSA-N 0.000 description 3
- LFUPTQIEOBBAJE-SECBINFHSA-N gtpl6348 Chemical compound C([C@H](O1)C)NC(C2=3)=C1C=NC=3SC(C1=O)=C2N=CN1C1=CC=C(Cl)C=C1 LFUPTQIEOBBAJE-SECBINFHSA-N 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- GXXXUZIRGXYDFP-UHFFFAOYSA-N 2-(4-methylphenyl)acetic acid Chemical compound CC1=CC=C(CC(O)=O)C=C1 GXXXUZIRGXYDFP-UHFFFAOYSA-N 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 2
- 241000819854 Dalbergia benthamii Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- -1 anticancer Substances 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- ODVLMCWNGKLROU-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)acetic acid Chemical compound OC(=O)CC1=CC=C2OCOC2=C1 ODVLMCWNGKLROU-UHFFFAOYSA-N 0.000 description 1
- YSQLGGQUQDTBSL-UHFFFAOYSA-N 2-(2,4,5-trifluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC(F)=C(F)C=C1F YSQLGGQUQDTBSL-UHFFFAOYSA-N 0.000 description 1
- GXMWLJKTGBZMBH-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(Cl)C=C1Cl GXMWLJKTGBZMBH-UHFFFAOYSA-N 0.000 description 1
- CDUSPKFHAVQVRQ-UHFFFAOYSA-N 2-(2-chloro-4-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(F)C=C1Cl CDUSPKFHAVQVRQ-UHFFFAOYSA-N 0.000 description 1
- MGKPFALCNDRSQD-UHFFFAOYSA-N 2-(4-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(F)C=C1 MGKPFALCNDRSQD-UHFFFAOYSA-N 0.000 description 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical group O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 1
- IPTYKTZRATXFRC-UHFFFAOYSA-N 3,3,3-trifluoro-2-phenyl-2-(trifluoromethyl)propanoic acid Chemical compound OC(=O)C(C(F)(F)F)(C(F)(F)F)C1=CC=CC=C1 IPTYKTZRATXFRC-UHFFFAOYSA-N 0.000 description 1
- GSRRYHALFWAEMW-UHFFFAOYSA-N 3-[2-(3-hydroxyphenyl)ethyl]-4-[(4-hydroxyphenyl)methyl]-5-methoxyphenol Chemical compound C=1C=C(O)C=CC=1CC=1C(OC)=CC(O)=CC=1CCC1=CC=CC(O)=C1 GSRRYHALFWAEMW-UHFFFAOYSA-N 0.000 description 1
- QOWSWEBLNVACCL-UHFFFAOYSA-N 4-Bromophenyl acetate Chemical compound OC(=O)CC1=CC=C(Br)C=C1 QOWSWEBLNVACCL-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 229910020366 ClO 4 Inorganic materials 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- PHHAXWBLJNBVNS-UHFFFAOYSA-N Isoglycycoumarin Natural products C=1C=2C(OC)=C3CCC(C)(C)OC3=CC=2OC(=O)C=1C1=CC=C(O)C=C1O PHHAXWBLJNBVNS-UHFFFAOYSA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 241000750718 Pterocarpus santalinus Species 0.000 description 1
- 241000863514 Sabicea Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- CRMBVHJMQTYDMJ-QZTJIDSGSA-N furanocoumarin Natural products CC(C)OC(C)(C)[C@H](O)COc1c2C=CC(=O)Oc2c(OC[C@@H](O)C(=C)C)c3occc13 CRMBVHJMQTYDMJ-QZTJIDSGSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- XGPBRZDOJDLKOT-UHFFFAOYSA-N praeruptorin A Natural products C1=CC(=O)OC2=C1C=CC1=C2C(OC(C)=O)C(OC(=O)C(C)=CC)C(C)(C)O1 XGPBRZDOJDLKOT-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a linear type licorice A analogue, which has the following structural general formula I:the invention also provides a preparation method of the linear type glabrous greenbrier rhizome A analogue, which takes methanol as a solvent and takes compounds 23a-23j as raw materials, after heating and dissolving, the raw materials are placed in a temperature of 0-5 ℃ for stirring reaction, and NaBH is added dropwise for 2-5 times in 1-3h 4 Dropwise adding 5% HCl solution into the reaction solution to finish the reaction, spinning part of methanol, extracting with ethyl acetate, mixing organic layers, sequentially using saturated NaHCO 3 The solution was washed with saturated saline, dried over anhydrous sodium sulfate, filtered, and recrystallized from methanol to obtain a linear type glabrous greenbrier rhizome a analogue. The linear type glabrous greenbrier rhizome A analogue provided by the invention has strong inhibition effect on white blood cells, lung cancer cells, cervical cancer cells and human breast cancer cells through in vitro anti-tumor experiments.
Description
Technical Field
The invention belongs to the field of medicinal chemistry. More specifically, the invention relates to a glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin, and preparation and application thereof.
Background
Cancer is a malignant tumor that originates in epithelial tissue, and cancer cells appear almost anywhere in the body, and these cells grow uncontrolled, spread out to attack surrounding normal tissue, and possibly metastasize to cause tumors to form in multiple parts of the body. According to the report of the world health organization, recently, nearly 1930 ten thousand people are diagnosed as newly increased cancer people worldwide, nearly 1000 ten thousand people die due to cancer, and the mortality rate is far higher than the sum of acquired immune deficiency syndrome and tuberculosis. At present, the main medical treatment means is surgical excision, and in order to better treat cancers, the U.S. food and drug administration approves anticancer drugs such as taxol, vincristine and the like to be marketed, but because of poor targeting selectivity of drug molecules and low bioavailability, normal cells are injured while cancer cells are attacked, so that the patients have side effects such as alopecia, low immunity, emaciation and the like. Therefore, searching for high-efficiency and low-toxicity anticancer drugs becomes one of the hot spots in the scientific research world.
Coumarin (Coumarin) is a compound with a benzopyrone structure, a benzene ring and an alpha-pyrone ring are core components of Coumarin, and due to conformational relation, chemical properties are stable, and more Coumarin analogues can be obtained through the introduction of various functional groups. Coumarin is classified according to basic structure, and can be classified into simple coumarin, furanocoumarin, pyranocoumarin, and other coumarin. Wherein pyranocoumarin derivatives are important components of natural active products, including anticancer, antioxidant, antiinflammatory, and anti-HIV. In recent years. The coumarin extracts a plurality of anticancer active ingredients, and provides a direction for developing new anticancer drugs.
The two Guangdong pterocarpus santalinus (Dalbergia benthamii Prain) is wood vine, and the medicinal part is stem, and is mainly distributed in Guangdong, guangxi, hainan and other places. A linear pyranocoumarin-rhizoma glycyrrhizae A is separated and identified from a Zhuang medicine Santalum album (Dalbergia benthamii Prain), and pharmacological experiments prove that the medicine has obvious effects of eliminating DPpH free radicals and ABTS+ and part free radicals and has a certain inhibition effect on tumor cells. However, the compound has poor water solubility and certain toxicity, and if the compound can be structurally optimized, the water solubility is improved, the toxicity is reduced, and the possibility of using the licorice A derivative as a clinical medicine is improved.
Disclosure of Invention
It is an object of the present invention to solve at least the above problems and to provide at least the advantages to be described later.
The invention takes the totally synthesized intermediate coumarin 9 and phenylacetic acid derivatives as raw materials to synthesize a series of linear type licorice A analogues 3-aryl-6, 7-pyranocoumarin 24a-24j with novel structure, high efficiency and low toxicity.
To achieve these objects and other advantages and in accordance with the purpose of the invention, there is provided a linear type glycyrrhiza glabra a analogue having the following structural formula I:
the general formula I contains compounds 24a-24j;
wherein,,
the preparation method of the linear type glabrous greenbrier rhizome A analogue comprises the steps of taking methanol as a solvent, taking compounds 23a-23j as raw materials, heating for dissolution, placing the mixture at 0-5 ℃ for stirring reaction, and dripping NaBH for 2-5 times in 1-3h 4 Dropwise adding 5% HCl solution into the reaction solution to finish the reaction, spinning part of methanol, extracting with ethyl acetate, mixing organic layers, sequentially using saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin 24a-24j;
wherein, the compounds 23a-23j have the following structural general formula II:
preferably, under the protection of inert gas, intermediate coumarin 9 and phenylacetic acid derivatives are used as raw materials, weak base triethylamine is used as a catalyst in an acetic anhydride/triethylamine reaction system, acetic anhydride is used as a solvent for heating reflux reaction, water is added after the reaction is finished, ethyl acetate is used for extraction, an organic layer is combined, anhydrous sodium sulfate is dried overnight, and column chromatography is used for purification, so that the compounds 23a-23j are obtained.
Preferably, 2,4, 6-trihydroxyacetophenone and 3, 3-dimethyl acrylic acid are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, ice water is poured into after the reaction is finished, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, and crude product silica gel column chromatography is carried out, thus obtaining intermediate coumarin 9.
The application of the linear type glabrous greenbrier rhizome A analogue is that the linear type glabrous greenbrier rhizome A analogue 3-aryl-6, 7-pyranocoumarin is used for preparing an anti-tumor medicament.
Preferably, the linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin is combined with auxiliary materials to prepare injection, tablet, pill, capsule, suspending agent or emulsion.
Preferably, the auxiliary materials are one or more of ethanol, propylene glycol, polyethylene glycol, diethylene glycol, glyceryl triacetate, glycerol, dextrin, povidone, stearyl alcohol, stearic acid, microcrystalline cellulose, starch, lactose, mannitol, sodium bicarbonate, calcium carbonate, low-substituted hydroxypropyl methylcellulose, magnesium stearate and talcum powder.
The invention at least comprises the following beneficial effects: the in vitro anti-tumor experiment shows that the linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin has strong anti-tumor activity. The preparation method can be applied to preparing antitumor drugs, and can be prepared into common pharmaceutical dosage forms, including injection, tablet, pill, capsule, suspending agent or emulsion.
Additional advantages, objects, and features of the invention will be set forth in part in the description which follows and in part will become apparent to those having ordinary skill in the art upon examination of the following or may be learned from practice of the invention.
Detailed Description
The present invention is described in further detail below to enable those skilled in the art to practice the invention by reference to the specification.
It will be understood that terms, such as "having," "including," and "comprising," as used herein, do not preclude the presence or addition of one or more other elements or groups thereof.
The experimental methods described in the following embodiments are conventional methods unless otherwise indicated, and the reagents and materials are commercially available.
The synthesis route of the linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin:
the invention provides a preparation method of the linear type glabrous greenbrier rhizome A analogue, which takes methanol as a solvent, takes compounds 23a-23j (1-10 mmol) as raw materials, heats and dissolves, then carries out stirring reaction at 0-5 ℃ for 2-5 times, and drops NaBH in 1-3h 4 (5-50 mmol) and dropwise adding acid solution such as HCl or sulfuric acid into the reaction solution to complete the reaction, spin-drying part of methanol, extracting with ethyl acetate, mixing organic layers, sequentially using saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain the linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin 24a-24j.
In one technical scheme, under the protection of inert gas, intermediate coumarin 9 (1-10 mmol) and phenylacetic acid derivative (1-10 mmol) are used as raw materials, weak base triethylamine (0.1-5 mmol) is used as a catalyst in an acetic anhydride/triethylamine reaction system, acetic anhydride (10-100 mmol) is used as a solvent, heating reflux reaction is carried out, water is added after the reaction is finished, ethyl acetate is used for extraction, an organic layer is combined, anhydrous sodium sulfate is dried overnight, and column chromatography purification is carried out to obtain the compounds 23a-23j.
In one technical scheme, 2,4, 6-trihydroxyacetophenone (1-50 mmol) and 3, 3-dimethyl acrylic acid (1-50 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and the crude product is filtered, and silica gel column chromatography is carried out to separate the crude product, thus obtaining the intermediate coumarin 9.
Example 1 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24a comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and p-methyl phenylacetic acid (1 mmol) as raw materials, heating and refluxing in an acetic anhydride/triethylamine reaction system by using weak base triethylamine (1.5 mmol) as a catalyst and acetic anhydride (40 mmol) as a solvent, adding water after the reaction is finished, extracting by using ethyl acetate, combining organic layers, drying by anhydrous sodium sulfate overnight, and purifying by column chromatography to obtain the compound 23a.
Compound 23a, 4,2 "-trimethyl-3-p-methoxyphenyl-5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -one: white single crystal with yield of 30%, m.p.177.2-179.5 ℃; HR-MS (ESI) m/z calculated for C 24 H 22 O 7 [M+H] + :423.1431,found:423.1434. 1 H NMR(400MHz,CDCl 3 )δ7.18(d,J=8.4Hz,2H),6.99(d,J=6.9Hz,2H),6.82(s,1H),3.86(s,3H,4′-OCH 3 ),2.72(s,2H),2.45(s,3H,4-CH 3 ),2.37(s,3H,12-CH 3 ),1.50(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ189.73,169.32,161.80,159.75,159.51,157.85,149.10,146.92,131.34,126.77,126.17,114.04,110.46,109.59,103.69,80.15,55.33,49.80,27.23,21.67,20.45.
Step three, taking methanol as a solvent, taking a compound 23a (8 mmol) as a raw material, heating for dissolution, then placing the mixture at 0-5 ℃ for stirring reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl are added dropwise into the reaction solution to finish the reaction, after part of methanol is dried, ethyl acetate is extracted, and thenAnd organic layer, sequentially with saturated NaHCO 3 Washing the solution with saturated saline water, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain the linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin.
The linear type gladiolus a analogue 3-aryl-6, 7-pyranocoumarin 24a, namely 4, 2' -trimethyl-3- (p-methoxyphenyl) -5-hydroxy-2 ' H, 3' H-6, 7-pyranocoumarin: orange crystals, yield 70%, m.p.261.4-263.2 ℃; HR-MS (ESI) m/z calculated for C 22 H 22 O 5 [M+H] + :367.1540,found:367.1546. 1 H NMR(500MHz,CDCl 3 )δ7.19(d,J=7.8Hz,2H),6.96(d,J=7.8Hz,2H),6.45(s,1H),5.26(s,1H,5-OH),3.84(s,3H,4′-OCH 3 ),2.59(s,2H),2.47(s,3H,4-CH 3 ),1.93(s,2H),1.37(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ161.64,159.03,156.68,153.53,152.58,149.52,131.59,127.49,123.05,113.89,103.67,103.26,97.96,74.91,55.29,31.78,26.45,21.38,16.65.
Example 2 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24b comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and p-tolueneacetic acid (1 mmol) as raw materials, heating and refluxing in an acetic anhydride/triethylamine reaction system with weak base triethylamine (1.5 mmol) as a catalyst and acetic anhydride (40 mmol) as a solvent, adding water after the reaction is finished, extracting with ethyl acetate, combining organic layers, drying with anhydrous sodium sulfate overnight, and purifying by column chromatography to obtain the compound 23b.
Compound 23b, 4,2 "-trimethyl-3-p-methylphenyl-5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -one: white colorSolid, yield 31%, m.p.200.2-201.9 ℃; HR-MS (ESI) m/z calculated for C 24 H 22 O 6 [M+H] + :407.1484,found:407.1486. 1 H NMR(400MHz,CDCl 3 )δ7.28(d,J=7.8Hz,2H),7.17(d,J=8.0Hz,2H),6.67(s,1H),2.73(s,2H),2.48(s,3H,12-CH 3 ),2.42(s,6H,4-CH 3 ),1.55(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ189.28,169.26,160.35,159.81,158.08,152.04,148.71,138.16,131.30,129.87,129.34,126.89,110.07,109.73,105.28,81.33,48.84,26.49,22.10,21.37,21.13.
Step three, taking methanol as a solvent, taking a compound 23b (8 mmol) as a raw material, heating for dissolution, then placing the mixture at 0-5 ℃ for stirring reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl were added dropwise to the reaction mixture to complete the reaction, after spinning down part of the methanol, ethyl acetate was used for extraction, the organic layers were combined and successively saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin 24b;
the linear type gladiolus a analogue 3-aryl-6, 7-pyranocoumarin 24b, namely 4, 2' -trimethyl-3- (p-methylphenyl) -5-hydroxy-2 ' h, 3' h-6, 7-pyranocoumarin: white solid, yield 69%, m.p.260.0-261.5 ℃; HR-MS (ESI) M/z calculated for C22H22O4[ M+H ]]+:351.1588,found:351.1589. 1 H NMR(500MHz,CDCl3)δ7.22(d,J=7.3Hz,2H),7.14(d,J=7.4Hz,2H),6.44(s,1H),5.44(s,1H,5-OH),2.58(t,J=6.0Hz,2H),2.45(s,3H,4′-CH3),2.37(s,3H,4-CH3),1.91(t,J=6.1Hz,2H),1.37(s,6H,2″-2×CH3) 13 C NMR(126MHz,CDCl3)δ161.61,156.73,153.55,152.72,149.67,137.43,132.33,130.21,129.16,123.31,103.67,103.41,97.90,74.92,31.79,26.46,21.36,21.34,16.66.
Example 3 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24c comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and p-fluorophenylacetic acid (1 mmol) as raw materials, heating and refluxing in an acetic anhydride/triethylamine reaction system by using weak base triethylamine (1.5 mmol) as a catalyst and acetic anhydride (40 mmol) as a solvent, adding water after the reaction is finished, extracting by using ethyl acetate, combining organic layers, drying by anhydrous sodium sulfate overnight, and purifying by column chromatography to obtain a compound 23c;
compound 23c, 4,2 "-trimethyl-3-p-fluorophenyl-5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -one: white needle crystals with the yield of 35 percent and m.p.218.1-219.5 ℃; HR-MS (ESI) m/z calculated for C 23 H 19 FO 6 [M+H] + :411.1231,found:411.1234. 1 H NMR(500MHz,CDCl 3 )δ7.24(d,J=14.8Hz,2H),7.15(d,J=7.8Hz,2H),6.82(s,1H),2.75(s,2H),2.44(s,3H,4-CH 3 ),2.33(s,3H,12-CH 3 ),1.49(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ189.67,169.27,163.60,162.02,159.46,157.86,149.27,147.5 5,131.97,131.90,126.06,115.82,110.55,109.33,103.77,80.25,49.78,27.21,21.66,20.43.
Step three, taking methanol as a solvent, taking a compound 23c (8 mmol) as a raw material, heating for dissolution, placing the mixture in a condition of stirring at 0-5 ℃ for reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl are added dropwise to the reaction solution to finish the reaction, after part of methanol is dried, ethyl acetate is extracted, the organic layers are combined, and then saturated NaHCO3 solution, saturated saline solution, anhydrous sodium sulfate for drying, filtration and methanol recrystallization are sequentially carried out, so that the linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24c is obtained.
The linear type gladiolus a analogue 3-aryl-6, 7-pyranocoumarin 24c, namely 4, 2' -trimethyl-3- (p-fluorophenyl) -5-hydroxy-2 ' h, 3' h-6, 7-pyranocoumarin: white solid, yield 72%, m.p.289.5-290.1 ℃; HR-MS (ESI) m/z calculated for C 21 H 20 FO 5 [M+Na] + :377.1152. 1 H NMR(500MHz,CDCl 3 )δ7.24(s,2H),7.12(t,J=7.8Hz,2H),6.46(s,1H),5.29(s,1H,5-OH),2.59(t,J=6.0Hz,2H),2.45(s,3H,4-CH 3 ),1.94(t,J=6.0Hz,2H),1.38(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,DMSO)δ162.87,160.92,157.19,155.24,153.26,150.93,133.04,132.97,121.36,115.38,106.60,104.35,96.42,75.43,31.78,26.64,21.90,17.67.
Example 4 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24d comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and p-chloroacetic acid (22 mmol) as raw materials, using weak base triethylamine as a catalyst in an acetic anhydride/triethylamine reaction system, heating and refluxing with acetic anhydride (40 mmol) as a solvent, adding water after the reaction is finished, extracting with ethyl acetate, combining organic layers, drying anhydrous sodium sulfate overnight, and purifying by column chromatography to obtain the compound 23d.
Compound 23d, 4,2 "-trimethyl-3-p-chlorophenyl-5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -one: white needle crystals with the yield of 34 percent and m.p.230.1-231.2 ℃; HR-MS (ESI) m/z calculated for C 23 H 19 ClO 6 [M+H] + :427.0939,found:427.0941. 1 H NMR(400MHz,CDCl 3 )δ7.44(d,J=8.5Hz,2H,),7.20(d,J=8.3Hz,2H),6.83(s,1H),2.73(s,2H),2.45(s,3H,4-CH 3 ),2.35(s,3H,12-CH 3 ),1.51(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ189.15,169.21,160.43,159.46,158.08,152.36,149.37,134.40,132.74,131.54,128.92,125.68,110.18,109.48,105.33,81.50,48.80,26.49,22.15,21.13.
Step three, taking methanol as a solvent, taking a compound 23d (8 mmol) as a raw material, heating for dissolution, placing the mixture in a condition of stirring at 0-5 ℃ for reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl were added dropwise to the reaction mixture to complete the reaction, after spinning down part of the methanol, ethyl acetate was used for extraction, the organic layers were combined and successively saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain the linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin 24d.
The linear type gladiolus a analogue 3-aryl-6, 7-pyranocoumarin 24d, namely 4, 2' -trimethyl-3- (p-chlorophenyl) -5-hydroxy-2 ' H, 3' H-6, 7-pyranocoumarin: white solid, yield 69%, m.p.255.4-256.8 ℃; HR-MS (ESI) m/z calculated for C 21 H 19 ClO 4 [M+H] + :371.1042,found:371.1043. 1 H NMR(500MHz,CDCl 3 )δ7.40(d,J=7.5Hz,2H),7.21(d,J=7.5Hz,2H),6.73(s,1H,H-8),2.70(t,J=6.5Hz,2H),2.43(s,3H,4-CH 3 ),1.82(t,J=6.3Hz,2H),1.38(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ161.99,157.54,153.77,152.10,147.34,133.93,133.65,131.97,128.68,121.26,105.36,104.87,94.94,75.90,31.34,26.76,22.10,16.91.
Example 5 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24e comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and 3, 4-methylenedioxyphenylacetic acid (1 mmol) as raw materials, heating and refluxing in a reaction system of acetic anhydride/triethylamine by using weak base triethylamine (1.5 mmol) as a catalyst and acetic anhydride (40 mmol) as a solvent, and after the reaction is finishedWater was added, extraction was performed with ethyl acetate, the organic layers were combined, dried over anhydrous sodium sulfate overnight, and purified by column chromatography to obtain compound 23e.
Compound 23e, 4,2 "-trimethyl-3- (3 ',4' -methylenedioxyphenyl) -5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -ketone: yellow solid, yield 38%, m.p.233.5-234.2 ℃; HR-MS (ESI) m/z calculated of C 24 H 20 O 8 [M+H] + :437.1226,found:437.1228. 1 H NMR(400MHz,CDCl 3 )δ6.89(d,J=7.9Hz,1H,H-6′),6.82(s,1H,H-8),6.73-6.68(m,2H,H-2′,5′),6.02(s,2H,H-7′),2.73(s,2H,H-3″),2.45(s,3H,4-CH 3 ),2.37(s,3H,12-CH 3 ),1.50(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ189.68,169.28,161.90,159.59,157.84,149.18,147.83,147.42,127.54,126.66,123.70,110.44,109.44,108.57,103.71,101.33,80.19,49.79,25.66,21.66,20.43.
Step three, taking methanol as a solvent, taking a compound 23e (8 mmol) as a raw material, heating for dissolution, placing the mixture in a condition of stirring at 0-5 ℃ for reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl were added dropwise to the reaction mixture to complete the reaction, after spinning down part of the methanol, ethyl acetate was used for extraction, the organic layers were combined and successively saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain the linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin 24e.
The linear type gladiolus a analogue 3-aryl-6, 7-pyranocoumarin 24e, namely 4, 2' -trimethyl-3- (3 ',4' -methylenedioxyphenyl) -5-hydroxy-2 ' h, 3' h-6, 7-pyranocoumarin: white solid, 71% yield, m.p.253.1-253.8 ℃; HR-MS (ESI) m/z calculated for C 22 H 20 O 6 [M+H] + :381.1327. 1 H NMR(500MHz,CDCl 3 )δ6.77(d,J=7.6Hz,1H),6.66-6.61(m,2H),6.35(s,1H),5.89(s,2H),5.55(s,1H,5-OH),2.51(t,J=6.1Hz,2H),2.39(s,3H,4-CH 3 ),1.83(t,J=6.2Hz,2H),1.29(s,6H,2″-2×CH 3 ). 13 CNMR(126MHz,CDCl 3 )δ160.64,155.81,152.41,151.80,149.37,146.57,146.05,127.83,122.80,121.69,109.76,107.37,102.54,100.08,96.78,73.92,30.71,25.40,20.35,15.60.
Example 6 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24f comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and 2-chloro-4-fluorophenylacetic acid (1 mmol) as raw materials, heating and refluxing in an acetic anhydride/triethylamine reaction system by using weak base triethylamine (1.5 mmol) as a catalyst and acetic anhydride (40 mmol) as a solvent, adding water after the reaction is finished, extracting by using ethyl acetate, combining organic layers, drying anhydrous sodium sulfate overnight, and purifying by column chromatography to obtain a compound 23f;
compound 23f, 4,2 "-trimethyl-3- (4 '-fluoro-2' -chlorophenyl) -5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -one: white solid, yield 39%, m.p.208.5-209.7 ℃; HR-MS (ESI) m/z calculated for C 23 H 18 ClFO 6 [M+H] + :445.0844,found:445.0846. 1 H NMR(500MHz,CDCl 3 )δ7.28(d,J=8.7Hz,1H),7.24-7.18(m,1H),7.10(t,J=7.9Hz,1H),6.68(s,1H),2.72(d,J=4.2Hz,2H),2.42(s,3H,4-CH3),2.40(s,3H,12-CH3),1.56(s,3H,2″-CH3),1.54(s,3H,2″-CH3). 13 CNMR(126MHz,CDCl 3 )δ189.10,169.25,163.50,161.50,160.53,158.39,152.57,151.07,135.32,132.61,129.49,123.46,117.45,114.79,110.18,109.11,105.41,81.57,48.77,26.63,21.59,21.13.
Step three, taking methanol as a solvent, taking a compound 23f (8 mmol) as a raw material, heating for dissolution, placing the mixture in a condition of stirring at 0-5 ℃ for reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl were added dropwise to the reaction mixture to complete the reaction, and after spinning down part of the methanol, ethyl acetate was extracted and combinedOrganic layer, sequentially with saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain the linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin 24f.
The linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24f, namely 4, 2' -trimethyl-3- (5 ' -fluoro-3 ' -chlorophenyl) -5-hydroxy-2 ' H, 3' H-6, 7-pyranocoumarin: white solid, yield 70%, m.p.271.4-273.5 ℃; HR-MS (ESI) m/z calculated for C 21 H 18 ClFO 5 [M+Na] + :427.0503,found:427.0595. 1 H NMR(500MHz,CDCl 3 )δ7.23(d,J=7.3Hz,2H),7.06(t,J=8.1Hz,1H),6.79(s,1H),2.71(d,J=6.1Hz,2H),2.37(s,3H,4-CH 3 ),1.82(d,J=6.1Hz,2H),1.39(s,3H,2″-CH 3 ),1.37(s,3H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ163.20,161.70,161.21,158.41,153.76,135.73,133.18,130.58,118.60,116.99,114.52,105.72,104.32,95.10,75.97,31.36,26.90,21.56,16.93.
Example 7 ]
A preparation method of 24g of linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and 4-bromophenylacetic acid (1 mmol) as raw materials, heating and refluxing in an acetic anhydride/triethylamine reaction system by using weak base triethylamine (1.5 mmol) as a catalyst and acetic anhydride (40 mmol) as a solvent, adding water after the reaction is finished, extracting by using ethyl acetate, combining organic layers, drying by anhydrous sodium sulfate overnight, and purifying by column chromatography to obtain 23g of a compound.
23g of compound, i.e. 4,2 "-trimethyl-3- (4' -bromophenyl) -5-acetoxy-2" H,3"H-6, 7-dihydropyran coumarin-4")Ketone: white solid, yield 37%, m.p.210.2-212.2 ℃; HR-MS (ESI) m/z calculated for C 23 H 19 BrO 6 [M+H] + :471.0432,found:471.0435. 1 H NMR(400MHz,CDCl 3 )δ7.61(d,J=8.4Hz,2H),7.16(d,J=8.4Hz,2H),6.67(s,1H),2.73(s,2H),2.47(s,3H,4-CH 3 ),2.42(s,3H,12-CH3),1.55(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl3)δ197.64,163.78,161.67,160.6 8,159.87,150.63,133.39,132.08,131.75,122.42,122.32,104.10,103.89,96.71,79.91,47.79,26.70,26.50,21.12.
Step three, taking methanol as a solvent, taking 23g (8 mmol) of a compound as a raw material, heating to dissolve, placing the mixture in a condition of stirring at 0-5 ℃ for reaction, and dripping NaBH for three times in 1.5h 4 (44 mmol) 9-10 drops of 5% HCl was added dropwise to the reaction solution to terminate the reaction, after spinning part of methanol, ethyl acetate was extracted, the organic layers were combined, washed successively with saturated NaHCO3 solution, saturated saline solution, dried over anhydrous sodium sulfate, filtered, and recrystallized from methanol to obtain 24g of the linear type Glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin.
24g of linear type gladiolus a analogue 3-aryl-6, 7-pyranocoumarin, namely 4,2 '-trimethyl-3- (4' -bromophenyl) -5-hydroxy-2 'H, 3' H-6, 7-pyranocoumarin: white solid, yield 70%, m.p.293.2-294.4 ℃; HR-MS (ESI) m/z calculated for C 21 H 19 BrO 4 [M+H] + :415.0539found:415.0547; 1 H NMR(500MHz,CDCl 3 )δ7.55(d,J=6.8Hz,2H),7.15(d,J=6.8Hz,2H),6.72(s,1H),5.26(s,1H,5-OH),2.70(s,2H,2.43(s,3H,4-CH 3 ),1.82(s,2H),1.38(s,6H,2″-2×CH 3 ). 13 CNMR(126MHz,CDCl 3 )δ161.09,157.05,153.63,152.79,150.14,134.33,132.22,131.63,122.16,121.96,103.37,98.04,75.03,31.73,26.45,21.37,16.63.
Example 8 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24h comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and 2, 4-dichlorophenylacetic acid (1 mmol) as raw materials, heating and refluxing in an acetic anhydride/triethylamine reaction system with weak base triethylamine as a catalyst and acetic anhydride (40 mmol) as a solvent, adding water after the reaction is finished, extracting with ethyl acetate, combining organic layers, drying with anhydrous sodium sulfate overnight, and purifying by column chromatography to obtain the compound 23h.
Compound 23h, 4,2 "-trimethyl-3- (2 ',4' -dichlorophenyl) -5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -ketone: white solid, yield 38%, m.p.230.5-231.6 ℃; HR-MS (ESI) m/z calculated for C 23 H 17 Cl 2 O 6 [M+H] + :461.0550,found:461.0552. 1 H NMR(400MHz,CDCl 3 )δ7.51(d,J=2.0Hz,1H),7.33(dd,J=8.2,2.0Hz,1H),7.16(d,J=8.2Hz,1H),6.64(s,1H),2.79(s,2H,),2.36(s,3H,4-CH 3 ),2.24(s,3H,12-CH 3 ),1.51(s,6H,2″-2×CH 3 ). 13 CNMR(101MHz,CDCl 3 )δ187.73,168.07,162.48,157.97,154.1,152.80,148.11,135.18,132.48,131.80,129.74,127.59,122.86,109.98,107.72,107.23,81.05,49.89,26.57,26.43,21.50,19.99.
Step three, taking methanol as a solvent, taking a compound 23h (8 mmol) as a raw material, heating for dissolving, placing the mixture in a temperature range of 0-5 ℃ for stirring reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl were added dropwise to the reaction mixture to complete the reaction, after spinning down part of the methanol, ethyl acetate was used for extraction, the organic layers were combined and successively saturated NaHCO 3 Washing the solution with saturated saline water, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain the linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin for 24h.
The linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin is 24h, namely 4,2 '-trimethyl-3- (4' -chlorophenyl) -5-hydroxy-2 'H, 3' H-6, 7-pyranocoumarin: a white solid was used as a solid,yield 72%, m.p.272.6-273.2 ℃, HR-MS (ESI) m/z calculated for C 21 H 18 C l2 O 4 [M+Na] + :427.0474,found:427.0481. 1 H NMR(500MHz,CDCl3)δ7.51(s,1H),7.32(d,J=8.0Hz,1H),7.19(d,J=7.7Hz,1H),6.83(s,1H),2.70(t,J=6.1Hz,2H),2.37(s,3H,4-CH3),1.82(t,J=6.1Hz,2H),1.39(s,6H,2″-2×CH3). 13 C NMR(126MHz,CDCl3)δ161.38,158.30,153.95,153.92,153.79,135.67,134.55,133.11,132.96,129.59,127.43,118.57,105.66,104.32,95.08,76.00,31.34,26.67,21.57,16.91.
Example 9 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24i comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and 2,4, 5-trifluoro phenylacetic acid (1 mmol) as raw materials, heating and refluxing in an acetic anhydride/triethylamine reaction system by using weak base triethylamine (1.5 mmol) as a catalyst and acetic anhydride (40 mmol) as a solvent, adding water after the reaction is finished, extracting by ethyl acetate, combining organic layers, drying by anhydrous sodium sulfate overnight, and purifying by column chromatography to obtain the compound 23i.
Compound 23i, 4,2 "-trimethyl-3- (2 ',4',5' -trifluorophenyl) -5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -one: white solid, 39% yield, m.p.174.1-175.5 ℃; HR-MS (ESI) m/z calculated for C 23 H 16 F 3 O 6 [M+H] + :447.1049,found:447.0496. 1 H NMR(500MHz,CDCl 3 )δ7.13(dd,J=16.1,7.7Hz,1H,),7.05(dd,J=16.1,7.7Hz,1H),6.67(s,1H),2.73(s,2H),2.48(s,3H,12-CH3),2.41(s,3H,4-CH 3 ),1.55(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ189.01,169.14,160.54,158.57,158.28,156.39,154.37,152.84,151.85,147.89,119.95,119.76,118.83,117.90,110.29,109.04,105.40,81.71,48.76,26.46,21.11,14.15.
Step three, taking methanol as a solvent, taking a compound 23i (8 mmol) as a raw material, heating for dissolution, placing the mixture in a condition of stirring at 0-5 ℃ for reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl were added dropwise to the reaction mixture to complete the reaction, after spinning down part of the methanol, ethyl acetate was used for extraction, the organic layers were combined and successively saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain the linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin 24i.
The linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24i is 4,2 '-trimethyl-3- (4' -chlorophenyl) -5-hydroxy-2 'H, 3' H-6, 7-pyranocoumarin: white solid, 70% yield, m.p.280.3-281.8 ℃, HR-MS (ESI) m/z calculated for C 21 H 17 F 3 O 4 [M+Na] + :413.0966,found:413.0972. 1 H NMR(500MHz,CDCl 3 )δ7.12(dd,J=16.1,8.2Hz,1H),7.02(dd,J=16.2,8.1Hz,1H),6.77(s,1H),2.70(t,J=6.4Hz,2H),2.45(s,3H,4-CH3),1.82(t,J=6.4Hz,2H),1.39(s,6H,2″-2×CH3) 13 C NMR(126MHz,CDCl3)δ161.36,158.31,154.67,153.98,153.74,149.56,147.76,143.80,120.30,114.08,105.96,105.66,105.57,104.46,95.00,76.11,31.30,26.76,21.89,16.89.
Example 10 ]
A preparation method of a linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24j comprises the following steps:
step one, 2,4,6, -trihydroxyacetophenone (10 mmol) and 3, 3-dimethyl acrylic acid (22 mmol) are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating pH to be neutral, and filtration is carried out, thus obtaining the white transparent crystal intermediate coumarin 9 by separating the crude product through silica gel column chromatography.
Step two, N 2 Under the protection of gas, using intermediate coumarin 9 (1 mmol) and bis (trifluoromethyl) phenylacetic acid (1 mmol) as raw materials, and adding acetic anhydrideIn a triethylamine reaction system, weak base triethylamine (1.5 mmol) is used as a catalyst, acetic anhydride (40 mmol) is used as a solvent for heating reflux reaction, after the reaction is finished, water is added, ethyl acetate is used for extraction, an organic layer is combined, anhydrous sodium sulfate is dried overnight, and column chromatography is used for purification, so that the compound 23j is obtained.
Compound 23j, i.e. 4,2 "-trimethyl-3- (3 ',5' -bistrifluoromethylphenyl) -5-acetoxy-2" h,3"h-6, 7-pyranocoumarin-4" -ketone: white solid, yield 38%, m.p.140.0-141.8 ℃; HR-MS (ESI) m/z calculated for C 25 H 18 F 6 O 6 [M+H]+:529.1080,found:529.1087. 1 H NMR(500MHz,CDCl 3 )δ7.76(s,1H),7.48(d,J=7.2Hz,2H),6.78(s,1H),2.70(s,2H),2.43(s,3H,12-CH3),2.40(s,3H,4-CH 3 ),1.43(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,CDCl 3 )δ189.45,169.07,162.5 6,158.75,157.83,149.72,148.89,136.33,132.18,130.69,124.13,122.41,122.01,110.79,108.81,103.90,80.48,49.73,26.70,21.63,20.50.
Step three, taking methanol as a solvent, taking a compound 23j (8 mmol) as a raw material, heating for dissolution, placing the mixture in a condition of stirring at 0-5 ℃ for reaction, and dripping NaBH for three times in 1.5h 4 (40 mmol) 9-10 drops of 5% HCl were added dropwise to the reaction mixture to complete the reaction, after spinning down part of the methanol, ethyl acetate was used for extraction, the organic layers were combined and successively saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain the linear type radix Glycyrrhizae analog 3-aryl-6, 7-pyranocoumarin 24j.
Linear type Glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24j, i.e. 4, 2' -trimethyl-3- (3 ',5' -bis (trifluoromethylphenyl) -5-hydroxy-2 ' H, 3' H-6, 7-pyranocoumarin: white solid with yield 69%, m.p.254-255 ℃, HR-MS (ESI) m/z: calculated for C 23 H 18 F 6 O 4 [M+H] + :473.1109,found:473.1110. 1 H NMR(500MHz,CDCl 3 )δ7.77(s,1H),7.50(d,J=7.2Hz,2H),6.77(s,1H),2.43(s,3H,12-CH 3 ),2.70(t,J=6.0Hz,2H),2.41(s,3H,4-CH 3 ),1.97(t,J=6.0Hz,2H),1.40(s,6H,2″-2×CH 3 ). 13 C NMR(126MHz,DMSO)δ160.25,157.66,155.64,153.77,151.78,139.05,132.22,130.47,124.90,122.73,119.13,105.80,103.31,94.43,76.23,31.14,26.71,22.17,17.21.
Example 11 ]
The linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin prepared in any one of embodiments 1-10 is combined with auxiliary materials to prepare injection, tablet, pill, capsule, suspending agent or emulsion. The chemical property and chemical structure of the linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin are kept stable.
Example 12 ]
The linear type licorice A analogue 3-aryl-6, 7-pyranocoumarin prepared in any one of the embodiments 1-10 and the auxiliary materials are one or more of ethanol, propylene glycol, polyethylene glycol, diethylene glycol, glyceryl triacetate, glycerol, dextrin, povidone, stearyl alcohol, stearic acid, microcrystalline cellulose, starch, lactose, mannitol, sodium bicarbonate, calcium carbonate, low-substituted hydroxypropyl methyl cellulose, magnesium stearate and talcum powder, and the linear type licorice A analogue is prepared into one of injection, tablet, pill, capsule, suspending agent or emulsion, wherein the chemical property and chemical structure of the licorice A derivative are kept stable.
< in vitro anti-tumor Activity experiment >
In vitro antitumor screening using MTS method
1) Inoculating cells: single cell suspension is prepared by culture solution (DMEM or RMPI 1640) containing 10% fetal bovine serum, 3000-15000 cells are inoculated into a 96-well plate, the volume of each well is 100 mu l, and the cells are inoculated and cultured in advance for 12-24 hours.
2) Adding a solution of a compound to be tested: the compound is dissolved by DMSO respectively, the initial concentration is set to 40 mu M, five tumor cells of leucocyte HL-60, liver cancer HepG2 tumor cell, cervical cancer Hela cell, human breast cancer cell MCF-7 and human normal liver cell LO2 are screened respectively, the final volume of each hole is 200 mu l, and 3 compound holes are arranged in each treatment.
3) Color development: after culturing at 37 ℃ for 48 hours, removing culture solution in the wells of the adherent cells, and adding 20 mu l of MTS solution and 100 mu l of culture solution into each well; suspension cells HL-60 were discarded with 100. Mu.l of culture supernatant and 20. Mu.l of MTS solution was added to each well; suspension cells MT-4 were directly added with 20. Mu.l MTS solution per well; 3 blank wells (mixed solution of 20. Mu.l MTS solution and 100. Mu.l culture solution) were used, and incubation was continued for 2 to 4 hours to allow the reaction to proceed sufficiently, and then the light absorption value was measured.
4) Colorimetric: the light absorption values of each well were read by a multifunctional microplate reader (MULTISKAN FC) at a wavelength of 492nm, and the results were recorded, and after data processing, inhibition results were obtained as shown in Table 1.
TABLE 1 IC of Linear Glycyrrhiza glabra A analog 3-aryl-6, 7-pyranocoumarin for different tumor cell lines 50
From the results shown in Table 1, the in vitro anti-tumor experiment shows that the linear type glabrous greenbrier rhizome A analogue 3-aryl-6, 7-pyranocoumarin has strong anti-tumor activity on leucocyte HL-60, liver cancer HepG2 tumor cell, cervical cancer Hea cell, human breast cancer cell MCF-7 and human normal liver cell LO 2. The invention provides a new thought for researching and developing new anti-tumor drugs.
Although embodiments of the present invention have been disclosed above, it is not limited to the use of the description and embodiments, it is well suited to various fields of use for the invention, and further modifications may be readily apparent to those skilled in the art, and accordingly, the invention is not limited to the particular details without departing from the general concepts defined in the claims and the equivalents thereof.
Claims (7)
1. The linear type licorice A analogue is characterized by having the following structural general formula I:
the general formula I is the following compounds 24b-24j;
wherein,,
24b:R 1 =CH 3 ,R 2 =R 3 =R 4 =H;
24c:R 1 =F,R 2 =R 3 =R 4 =H;24d:R 1 =Cl,R 2 =R 3 =R 4 =H;
24e:R 1 +R 3 =OCH 2 O,R 2 =R 4 =H;24f:R 1 =F,R 2 =Cl,R 3 =R 4 =H;
24g:R 1 =Br,R 2 =R 3 =R 4 =H;24h:R 1 =Cl,R 2 =Cl,R 3 =R 4 =H;
24i:R 1 =R 2 =R 4 =F,R 3 =H;24j:R 1 =R 2 =H,R 3 =R 4 =CF 3 。
2. the method for preparing linear type glabrous greenbrier rhizome A analogue as claimed in claim 1, wherein methanol is used as a solvent, the compound 23b-23j is used as a raw material, after heating and dissolving, the mixture is stirred and reacted at 0-5 ℃ for 2-5 times in 1-3 hours, and NaBH is added dropwise 4 Dropwise adding acid solution into the reaction solution to finish the reaction, spin-drying part of methanol, extracting with ethyl acetate, mixing organic layers, sequentially using saturated NaHCO 3 Washing the solution with saturated saline, drying with anhydrous sodium sulfate, filtering, recrystallizing with methanol to obtain linear type radix Glycyrrhizae analog A, 3-aryl-6, 7-pyranocoumarin 24b-24j;
wherein, the compounds 23b-23j have the following structural general formula II:
23b:R 1 =CH 3 ,R 2 =R 3 =R 4 =H;
23c:R 1 =F,R 2 =R 3 =R 4 =H;23d:R 1 =Cl,R 2 =R 3 =R 4 =H;
23e:R 1 +R 3 =OCH 2 O,R 2 =R 4 =H;23f:R 1 =F,R 2 =Cl,R 3 =R 4 =H;
23g:R 1 =Br,R 2 =R 3 =R 4 =H;23h:R 1 =Cl,R 2 =Cl,R 3 =R 4 =H;
23i:R 1 =R 2 =R 4 =F,R 3 =H;23j:R 1 =R 2 =H,R 3 =R 4 =CF 3 。
3. the method for preparing the linear type glabrous greenbrier rhizome A analogue according to claim 2, which is characterized in that under the protection of inert gas, intermediate coumarin 9 and phenylacetic acid derivatives are used as raw materials, weak base triethylamine is used as a catalyst in an acetic anhydride/triethylamine reaction system, acetic anhydride is used as a solvent for heating reflux reaction, after the reaction is finished, water is added, ethyl acetate is used for extraction, an organic layer is combined, anhydrous sodium sulfate is dried overnight, and the compound 23b-23j is obtained through column chromatography purification;
wherein, the structural formula of the intermediate coumarin 9 is as follows:
the structural formula of the phenylacetic acid derivative is as follows:
in the structural formula:
b:R 1 =CH 3 ,R 2 =R 3 =R 4 =H;
c:R 1 =F,R 2 =R 3 =R 4 =H;d:R 1 =Cl,R 2 =R 3 =R 4 =H;
e:R 1 +R 3 =OCH 2 O,R 2 =R 4 =H;f:R 1 =F,R 2 =Cl,R 3 =R 4 =H;
g:R 1 =Br,R 2 =R 3 =R 4 =H;h:R 1 =Cl,R 2 =Cl,R 3 =R 4 =H;
i:R 1 =R 2 =R 4 =F,R 3 =H;j:R 1 =R 2 =H,R 3 =R 4 =CF 3 。
4. the method for preparing the linear type glabrous greenbrier rhizome A analogue according to claim 3, which is characterized in that 2,4, 6-trihydroxy acetophenone and 3, 3-dimethyl acrylic acid are used as raw materials, anhydrous dioxane is used as solvent oil bath for heating reflux reaction, after the reaction is finished, ice water is poured in, saturated potassium carbonate is used for regulating the pH value to be neutral, and the crude product is filtered, and silica gel column chromatography is carried out to separate the crude product, thus obtaining the intermediate coumarin 9.
5. The use of the linear type gladiolus a analogue according to claim 1, wherein the linear type gladiolus a analogue 3-aryl-6, 7-pyranocoumarin 24b is used for preparing a medicament for inhibiting liver cancer HepG2 tumor cells, cervical cancer Hela cells, human breast cancer cells MCF-7, human normal liver cells LO 2; the linear type glycyrrhiza glabra A analogue 3-aryl-6, 7-pyranocoumarin 24c is used for preparing medicines for inhibiting leucocyte HL-60; the linear type glabrous greenbrier rhizome A analogue 3-aryl-6, 7-pyranocoumarin 24d is used for preparing medicines for inhibiting leucocyte HL-60, liver cancer HepG2 tumor cells, cervical cancer HeLa cells and human normal liver cell LO 2; the linear type glabrous greenbrier rhizome A analogue 3-aryl-6, 7-pyranocoumarin 24e, 24f, 24h, 24i or 24j is used for preparing medicines for inhibiting leucocyte HL-60, liver cancer HepG2 tumor cell, cervical cancer Hea cell, human breast cancer cell MCF-7 and human normal liver cell LO 2; the linear type glabrous greenbrier rhizome A analogue 3-aryl-6, 7-pyranocoumarin 24g is used for preparing medicaments for inhibiting liver cancer HepG2 tumor cells, cervical cancer Hela cells, human breast cancer cells MCF-7 and human normal liver cells LO 2.
6. The use of the linear type gladiolus a analogue according to claim 5, wherein the linear type gladiolus a analogue 3-aryl-6, 7-pyranocoumarin is combined with auxiliary materials to prepare injection, tablet, pill, capsule, suspending agent or emulsion.
7. The use of the linear type glabrous greenbrier rhizome A analogue as claimed in claim 6, wherein the auxiliary material is one or more of ethanol, propylene glycol, polyethylene glycol, diethylene glycol, glyceryl triacetate, glycerol, dextrin, povidone, stearyl alcohol, stearic acid, microcrystalline cellulose, starch, lactose, mannitol, sodium bicarbonate, calcium carbonate, low-substituted hydroxypropyl methyl cellulose, magnesium stearate and talcum powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210749248.2A CN115197236B (en) | 2022-06-29 | 2022-06-29 | Linear type glabra A analogue and preparation and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210749248.2A CN115197236B (en) | 2022-06-29 | 2022-06-29 | Linear type glabra A analogue and preparation and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115197236A CN115197236A (en) | 2022-10-18 |
CN115197236B true CN115197236B (en) | 2023-09-19 |
Family
ID=83578088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210749248.2A Active CN115197236B (en) | 2022-06-29 | 2022-06-29 | Linear type glabra A analogue and preparation and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115197236B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990008529A2 (en) * | 1989-01-23 | 1990-08-09 | Lehigh University | 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor |
CN104341430A (en) * | 2014-09-30 | 2015-02-11 | 广西中医药大学 | 3-phenylcoumarin robustic acid as well as extraction method and application thereof |
CN111217825A (en) * | 2020-02-25 | 2020-06-02 | 广西中医药大学 | 4-O-aminopropyl earth licorice A derivative and preparation and application thereof |
-
2022
- 2022-06-29 CN CN202210749248.2A patent/CN115197236B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990008529A2 (en) * | 1989-01-23 | 1990-08-09 | Lehigh University | 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor |
CN104341430A (en) * | 2014-09-30 | 2015-02-11 | 广西中医药大学 | 3-phenylcoumarin robustic acid as well as extraction method and application thereof |
CN111217825A (en) * | 2020-02-25 | 2020-06-02 | 广西中医药大学 | 4-O-aminopropyl earth licorice A derivative and preparation and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN115197236A (en) | 2022-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102659735B (en) | quercetin-3-O-acyl ester and preparation method thereof | |
CN108727316B (en) | Benzofuran-2-one compound and preparation method and application thereof | |
EP1980248B1 (en) | Composition for treating cancer cells and synthetic method for the same | |
CN110627755A (en) | Gamma-butyrolactone dimer anticancer compound and preparation method thereof | |
CN109970679A (en) | Paeonol thiazole and its preparation method and application | |
CN111606917B (en) | Abietane compound with C-ring-fused lactone ring novel skeleton and preparation method and application thereof | |
CN115197236B (en) | Linear type glabra A analogue and preparation and application thereof | |
CN107722101A (en) | Steroidal pyridine derivatives and its preparation method and application | |
EP0269754A1 (en) | Novel biphenyl derivatives, process for their preparation, and their use | |
CN111217825B (en) | 4-O-aminopropyl earth licorice A derivative and preparation and application thereof | |
JPH01125320A (en) | Testosterone-5alpha-reductase inhibitor | |
CN112300118B (en) | Benzothiopyranone compound and preparation method and application thereof | |
US7842721B2 (en) | Composition for treating cancer cells and synthetic method for the same | |
CN115322204B (en) | Preparation method and application of radix glycyrrhizae glabra A and derivatives thereof | |
CN102443005A (en) | Spiroheterocycle compound of chalcone and application of spiroheterocycle compound | |
CN107325031B (en) | One kind benzophenone containing selenium and its derivative and preparation method and application in preparation of anti-tumor drugs | |
CN112778201B (en) | Benzo [ b ] azepine-chalcone hybrid and preparation method and application thereof | |
CN111995605A (en) | Chrysin cinnamate or its derivative and its preparation method | |
CN111217824B (en) | 4-O-arylaminopropyl glycyrrhiza A derivative and preparation and application thereof | |
CN104672136A (en) | 1-substituted phenanthryl-N-alkyl (acyl)-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinoline derivative as well as preparation method and purpose thereof | |
JPH064615B2 (en) | Novel triene derivative with chromene structure | |
CN108658957A (en) | It a kind of substitution chromene alkoxide compound and its is applied in preparing anticancer drug | |
Banday et al. | Structure-activity relationship of anticancer potential of 4-hydroxycoumarin and its derivatives: A comparative study | |
CN102675273A (en) | 3-aryl-8-allyl-7-hydroxy (methoxyl) coumarin and application in preparation of antitumor drugs | |
KR0171692B1 (en) | Chromone derivative and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |